COMMUNIQUÉS West-GlobeNewswire

R1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare Transformation
28/05/2025
Investment Follows Recent R37 Launch MURRAY, Utah, May 28, 2025 (GLOBE NEWSWIRE) -- R1, an industry leader in managing and intelligently automating healthcare revenue management with over 20 years of experience, today [...]
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
28/05/2025
PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released [...]
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2025
28/05/2025
Allschwil, Switzerland – May 28, 2025 At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all proposals by the Board of Directors. [...]
Trading in GN Store Nord shares by board members, executives and associated persons
28/05/2025
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Besample Raises $1.1M to Take Behavioral Science Beyond the West
28/05/2025
Led by Gutter Capital, the pre-seed round supports a new platform that tackles Western data bias in behavioral science and AI NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Besample , a platform enabling researchers to [...]
DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa
28/05/2025
Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa. Dermaliq’s proprietary [...]
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
28/05/2025
PARIS and CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to [...]
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global Healthcare
28/05/2025
PARIS et CAMBRIDGE, Mass., 28 mai 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
Pharming Group to participate in June investor conferences
28/05/2025
Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month [...]
InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum
28/05/2025
JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Independent [...]
SBC Medical Announces Attendance at Upcoming Investor Events
28/05/2025
IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced [...]
Aja Health and Wellness Inc. Announces Launch of Nasal Product for Migraine Headache Relief and Provides Update on Delay in Filing Financial Statements
28/05/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly owned [...]
Jamieson Wellness Inc. Announces Voting Results from 2025 Annual Meeting of Shareholders
28/05/2025
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of [...]
Yerbaé Partners with National Foodservice Provider, Guckenheimer
28/05/2025
New partnership brings Yerbaé’s functional beverages to Guckenheimer’s national café & market business and expands reach for Safety Shot at the conclusion of the companies’ merger SCOTTSDALE, Ariz., May 27, 2025 ( [...]
Aptose Announces Results from Annual and Special Meeting of Shareholders
27/05/2025
SAN DIEGO and TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple [...]
Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders
27/05/2025
MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on [...]
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
27/05/2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease [...]
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
27/05/2025
SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through [...]
Galapagos Creates New Subscription Right Plan
27/05/2025
Mechelen, Belgium; May 27, 2025, 22:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 925,000 subscription rights under a new subscription [...]

Pages